Biogen False Claims Act Suit Largely Survives Dismissal In Federal Court

Mealey's (May 2, 2018, 10:40 AM EDT) -- BOSTON — A Massachusetts federal judge on April 27 declined to dismiss most of the claims by two whistleblowers that Biogen Idec Inc. violated the False Claims Act by paying illegal kickbacks to doctors to prescribe three multiple sclerosis drugs and causing false claims to be paid by the federal government (United States of America, et al., ex rel. Michael Bawduniak, et al. v. Biogen Idec, Inc., No. 12-10601, D. Mass., 2018 U.S. Dist. LEXIS 70848)....

Attached Documents

Related Sections